Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study
Michelle C. Janelsins(University of Rochester), Gary R. Morrow(University of Rochester Medical Center), Tim A. Ahles(Memorial Sloan Kettering Cancer Center), Luke J. Peppone(University of Rochester Medical Center), Lori M. Minasian(National Cancer Institute), Supriya G. Mohile(University of Rochester Medical Center), Judith O. Hopkins(Novant Health), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Jodi Geer(Metro-Minnesota Community Oncology Research Consortium), Shaker R. Dakhil(Cancer Center of Kansas), Allison Magnuson(University of Rochester Medical Center), Oxana Palesh(Virginia Commonwealth University), Ann M. O’Mara(National Cancer Institute), AnnaLynn M. Williams(University of Rochester)
Cited by 159
Related Papers
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670